5th European Biosimilars Congress 2016

Topics

• Emerging Biosimilars in Therapeutics
• Challenges and Regulatory Approach for Biosimilars
• Emerging Biologics in Therapeutics
• Clinical Studies and Clinicians Prospects for Biosimilars
• Biosimilars Innovator Pharmaceutical Products
• Globalization of Biosimilars
• Bioequivalence Assessment
• Biosimilar Analytical Strategies
• Plant Produced Biosimilar Products
• BCS & IVIVC Based Biowaivers
• Regulatory Affairs and Intellectual Property Rights
• Pharmacovigilance and its Challenges
• Biosimilar Companies and Market Analysis
• Current Challenges in Advancement of Biologics

Who should Attend

Senior attendees involved or interested in:

• Biosimilars
• Biologics
• Biobetters
• Biowaivers
• Biotechnology